Enhancing the Delivery of Erythropoietin and Its Variants into the Ischemic Brain
The hematopoietic growth factor erythropoietin (EPO) and its neuroprotective, but not hematopoietic, variants asialoEPO, carbamylated EPO (CEPO), and low sialic acid EPO (Neuro-EPO) are attractive candidates for stroke treatment. Due to their large molecular weight, these proteins enter the brain on...
Saved in:
| Main Author: | Dirk M. Hermann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2009.104 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic effect of erythropoietin and its derivatives in the treatment of acute ischemic stroke
by: Ramón Rama, et al.
Published: (2025-04-01) -
Diagnostic Value of Erythropoietin Levels in Umbilical Cord Blood in Hypoxic-Ischemic Brain Injury: Clinical Observational Cross-Sectional Study
by: S. B. Berezhanskaya, et al.
Published: (2022-12-01) -
Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector
by: Z. Du, et al.
Published: (2025-04-01) -
Recombinant erythropoietin in humans has a prolonged effect on circulating erythropoietin isoform distribution.
by: Niels Jacob Aachmann-Andersen, et al.
Published: (2014-01-01) -
Hematologic safety of chronic brain‐penetrating erythropoietin dosing in APP/PS1 mice
by: Jiahong Sun, et al.
Published: (2019-01-01)